The partnership between is expected to improve access and help overcome gaps in care for consumers.
CVS did it with Caremark, Rite Aid did it with Envision, and now it’s Walgreens’ turn. The partnership between Walgreens Boots Alliance and OptumRx (the pharmacy benefit management wing of UnitedHealth) is expected to improve access to drugs for consumers.
According to an announcement by the UnitedHealth group, the integration will allow:
“We are excited to be working with Walgreens to create a new pharmacy solution that provides convenience and cost savings, and goes beyond filling prescriptions to deliver a more valuable pharmacy and health management experience for consumers,” said Larry Renfro, chief executive officer of Optum, in a statement.
Analysts predict that this partnership will help boost drug sales for Walgreens. However, some members with drug coverage from Optum might end up having to fill-in their prescriptions only at a Walgreens pharmacy, depending on the contract signed by their employers or drug benefits plan.
Both Walgreens and OptumRx expect that this partnership would have a significant impact on patient adherence and closing the gaps in care. “The deal will give pharmacists more access to information that will help them counsel patients who are on multiple drugs, aren’t getting refills, or taking pills that shouldn’t be taken together,” said Mark Thierer, chief executive officer of OptumRx.
The integrated pharmacy care will be available to commercial clients at the beginning of 2017.
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More